Endovascular Treatment for Mild Stroke With Acute Anterior Circulation Large Vessel Occlusion

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

February 7, 2024

Primary Completion Date

August 31, 2027

Study Completion Date

December 31, 2027

Conditions
Endovascular Treatment
Interventions
OTHER

Experimental group:Intervention Group

Intervention Group:Interventionist choose the optimal endovascular treatment (EVT) strategy and device based on the patient's condition and local guidelines. The patient will receive the best medical treatment according to the local guidelines.

OTHER

Control group:best medical treatment

Best medical treatment:Patients will receive the best medical treatment according to local guidelines, including antiplatelet agents, anticoagulants, thrombolysis, etc., but not any EVT. In the control arm, rescue EVT is allowed in patients with disease progression leading to an increase in NIHSS≥4 and excluding the impact of non-stroke factors, and the onset-to-treatment time is within 24 hours.

Trial Locations (1)

363000

RECRUITING

Zhangzhou Municipal Hospital, Zhangzhou

All Listed Sponsors
collaborator

Changhai Hospital

OTHER

collaborator

The Affiliated Hospital Of Guizhou Medical University

OTHER

lead

Zhangzhou Municipal Hospital

OTHER